2019 Year in Review for Drug and Device Advertising and Promotion – Lessons Learned from 2019 FDA Enforcement Letters and Other Key Developments



12:00pm - 1:30pm

Please join our experienced panel for a review of key takeaways from the FDA’s 2019 drug and device advertising and promotion enforcement letters and a discussion of related regulatory developments. Learn the issues that were most commonly raised in last year’s letters, as well as other important legal and regulatory developments, and what these could mean for your business, including:

-OPDP, APLB, and CDRH enforcement overview
-2019 advertising and promotion guidance documents
-OPDP research and guidance agendas
-Predictions for what is expected in 2020

You do not have to be a client to attend, and there is no charge.

Click Here for More Information

Contact: Miranda Holizna
Contact Email: